Nervous System News and Research

Latest Nervous System News and Research

What are the benefits of exercise on cardiovascular health?

Researchers estimated the impact of exercise on cardiovascular (CV) health.

1 May 2023

Humans can perceive a greater range of blue tones than monkeys

New findings in color vision research imply that humans can perceive a greater range of blue tones than monkeys do.

28 Apr 2023

The association between breastfeeding, drug exposure, and infant outcomes: more research is needed

Researchers explored the data linking breastfeeding, infant outcomes, and drug exposure.

28 Apr 2023

Climate change linked to changes in gut microbiota and aging process

Research paper explores the relationship between aging, gut microbiota, and climate change. It discusses how climate change can affect the composition of gut microbiota, which in turn can impact the aging process.

26 Apr 2023

Ingestible capsule uses electricity to boost production of hunger-regulating hormone

Hormones released by the stomach, such as ghrelin, play a key role in stimulating appetite. These hormones are produced by endocrine cells that are part of the enteric nervous system, which controls hunger, nausea, and feelings of fullness.

26 Apr 2023

Rheumatologists can play a key role in diagnosing and treating neurologic Lyme disease

Rheumatologists can play a major role in diagnosing and treating neurologic Lyme disease, according to a paper published in the journal Pathogens by an immunologist and rheumatologists at Rutgers New Jersey Medical School.

26 Apr 2023

COVID-19 mitigation strategies decreased childhood medical mortality in the US

Research examines the impact of pandemic mitigation strategies on childhood mortality during the first year of the COVID-19 pandemic in the United States.

25 Apr 2023

Neutrophils found to play a key role in fibromyalgia pain

Targeting neutrophil activity and interactions with sensory neurons may be a potential approach for treating fibromyalgia pain.

25 Apr 2023

Study finds biomarker pattern in children with COVID 19-linked multisystem inflammatory syndrome

Children with multisystem inflammatory syndrome (MIS-C) — a rare condition linked with the virus that causes COVID-19 — have biochemical indicators of cell injury and cell death that are distinct from other children with COVID-19, according to a study funded by the National Institutes of Health.

25 Apr 2023

Depressed? Anxious? Air pollution may be a factor

In the 1990s, residents of Mexico City noticed their dogs acting strangely — some didn't recognize their owners, and the animals' sleep patterns had changed.

25 Apr 2023

Targeting antiviral pathway may offer a new approach to fight Alzheimer's, frontotemporal dementia

Targeting part of an antiviral pathway triggered by the accumulation of a key pathogen shared in Alzheimer's disease and frontotemporal dementia may one day offer a new therapeutic approach to deterring or delaying cognitive decline, according to preclinical research led by Weill Cornell Medicine scientists.

24 Apr 2023

Mount Sinai announces creation of the Institute for Regenerative Medicine

Regenerative medicine - the process of replacing, engineering or regenerating human cells, tissues or organs - holds exciting potential for the field of health care.

24 Apr 2023

Researchers develop a backpack-based myeloid cell therapy for MS patients

Multiple sclerosis (MS) is a devastating autoimmune disease that destroys the protective myelin covering around nerves, disrupting communication between the brain and body, and causing patients' ability to move and function to progressively decline.

21 Apr 2023

Childhood adversity may increase risk of developing type 2 diabetes in early adulthood

A new study published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD])finds that individuals who experienced childhood adversity are at increased risk of developing type 2 diabetes (T2D) in early adulthood.

21 Apr 2023

Most kids recover from Lyme disease within six months of completing antibiotic treatment

A majority of parents of children diagnosed with Lyme disease reported that their kids recovered within six months of completing antibiotic treatment, according to a new joint study from Children's National Research Institute and the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, published in Pediatric Research.

21 Apr 2023

Research reveals a more effective treatment for multiple sclerosis patients

Degeneration of myelin, an insulating sheath required for rapid communication between nerve cells, and neuroinflammation are notable hallmarks of Multiple Sclerosis (MS) and related neurodegenerative disorders such as Alzheimer's disease or Huntington's disease that affect roughly 2.8 million people in the world.

21 Apr 2023

Neighborhood social factors may be linked to epilepsy outcomes

People with epilepsy living in disadvantaged neighborhoods - areas with higher poverty levels and fewer educational and employment opportunities - may be more likely to have memory, thinking, and mental health problems compared to people with epilepsy living in neighborhoods with fewer disadvantages, according to new research published in the April 19, 2023, online issue of Neurology, the medical journal of the American Academy of Neurology.

20 Apr 2023

Teriflunomide may delay first symptoms of multiple sclerosis, study shows

A drug called teriflunomide may delay first symptoms for people whose magnetic resonance imaging (MRI) scans show signs of multiple sclerosis (MS) even though they do not yet have symptoms of the disease.

20 Apr 2023

New drug may offer relief for people with difficult-to-treat migraine

The drug atogepant may help prevent migraines for people who have had no success with other preventive drugs, according to a preliminary study released April 20, 2023, which will be presented at the American Academy of Neurology's 75th Annual Meeting being held in person in Boston and live online from April 22-27, 2023.

20 Apr 2023

Using engineered stem cells to treat ALS and retinitis pigmentosa

Cedars-Sinai investigators are developing a novel way to treat amyotrophic lateral sclerosis (ALS) and retinitis pigmentosa using engineered stem cells that may eventually lead to personalized treatments.

20 Apr 2023